QSAM Biosciences, Inc.

OTCPK:QSAM Stock Report

Market Cap: US$34.5m

QSAM Biosciences Balance Sheet Health

Financial Health criteria checks 4/6

QSAM Biosciences has a total shareholder equity of $672.3K and total debt of $7.5K, which brings its debt-to-equity ratio to 1.1%. Its total assets and total liabilities are $1.7M and $1.0M respectively.

Key information

1.1%

Debt to equity ratio

US$7.50k

Debt

Interest coverage ration/a
CashUS$1.39m
EquityUS$672.35k
Total liabilitiesUS$1.03m
Total assetsUS$1.71m

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: QSAM's short term assets ($1.7M) exceed its short term liabilities ($1.0M).

Long Term Liabilities: QSAM has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: QSAM has more cash than its total debt.

Reducing Debt: QSAM had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: QSAM has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: QSAM has less than a year of cash runway if free cash flow continues to reduce at historical rates of 20.9% each year


Discover healthy companies